Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University of Turin, Italy clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy, Ireland, France and India registers with University of Turin, Italy as lead sponsor. Synced 15 Nov 2026
17Current trials
12Recruiting now
8Drugs in these trials
4Trial registers
At a glance

University of Turin, Italy is the lead sponsor of 17 current clinical trials in our Italy, Ireland, France and India registers. 12 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Daratumumab, Dexamethasone and Lenalidomide. The most-studied condition is Airway Complication of Anesthesia.

ClinicalTrials.gov trials by status

  • Recruiting1271%
  • Not yet open212%
  • Active, closed16%
  • By invitation212%

Trials by phase

  • Observational847%
  • Not applicable741%
  • Phase 316%
  • Phase 416%
01

Clinical trials sponsored by University of Turin, Italy

17 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
NCT05759299 · Airway Complication of Anesthesia
Observational Recruiting 2024-01 Ireland, India, France, Italy
Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)
NCT07580196 · ClinicalTrials.gov ↗ · Prostate Cancer
Not applicable Recruiting 2026-03 Italy
Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation
NCT05014581 · Critical Illness, Respiratory Failure
Phase 3 Recruiting 2024-08 Ireland, France, Italy
Effects Of Periodontal Therapy In Patients With Inflammatory Bowel Disease
NCT07905859 · ClinicalTrials.gov ↗ · Periodontal Diseases, IBD, Dysbiosis
Observational Recruiting 2026-03 Italy
Brief Clinical Psychological Intervention With Biofeedback in Head and Neck Cancer
NCT07712120 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Surgery for Head and Neck Cancer Patients, Demolitive Surgical Procedures on the Oral Cavity or Oropharynx, With or Without Simultaneous Reconstruction Using Flaps
Not applicable Recruiting 2025-11 Italy
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06715046 · ClinicalTrials.gov ↗ · GVHD - Graft-Versus-Host Disease, Infections After HSCT, Transplant Associated Microangiopathy TAM
Observational Recruiting 2024-01 Italy
Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms
NCT07033741 · ClinicalTrials.gov ↗ · Depression, Anxiety, Post-traumatic Stress Symptoms, Dissociation
Observational Recruiting 2025-01 Italy
Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid Restriction
NCT07528365 · ClinicalTrials.gov ↗ · SIAD - Syndrome of Inappropriate Antidiuresis
Not applicable Recruiting 2024-09 Italy
Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer
NCT04871399 · ClinicalTrials.gov ↗ · Colon Cancer
Not applicable Recruiting 2020-07 Italy
BioMArkeRs of INflammation, Infection, and Immunity in the Critical Area (MARINA): the Use of Inflammatory and Immunity Biomarkers as Early Predictors of Clinical Severity, Organ Damage, Response to Treatment, and Infectious Complications in Patients Admitted to the Critical Care Area.
NCT07682766 · ClinicalTrials.gov ↗ · Septic Shock, Immunocompromised Patients
Observational Recruiting 2025-01 Italy
Italian Treatment Free Remission Registry
NCT04769947 · ClinicalTrials.gov ↗ · Treatment Free Remission, Chronic Myeloid Leukemia
Observational Recruiting 2021-08 Italy
Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Derivo 2
NCT06325371 · ClinicalTrials.gov ↗ · Aneurysm Abdominal, Arterial Aneurysm
Observational Recruiting 2024-11 Italy
Low VS High-fidelity Interprofessional Simulation for ABG Skills Acquisition
NCT06493188 · ClinicalTrials.gov ↗ · Interprofessional Relations, Self Efficacy, Knowledge, Attitudes, Practice
Not applicable Not yet open 2026-03 Italy
Neonatal Catheter Lock for Infection Prevention
NCT07585188 · ClinicalTrials.gov ↗ · CLABSI - Central Line Associated Bloodstream Infection, CRBSI - Catheter Related Bloodstream Infection, Neonatal Sepsis, Late-Onset
Not applicable Not yet open 2026-10 Italy
Implant Survival After Surgical Treatment of Peri-implantitis of Infra-bony Defects
NCT07809334 · ClinicalTrials.gov ↗ · Peri-implantitis
Observational By invitation 2026-09 Italy
Biotics Intervention Oriented to Rescue From Environmental Pollution Inflammatory Responses
NCT07418489 · ClinicalTrials.gov ↗ · Healthy 70 Street Market Vendors Working in Highly-polluted Areas of Turin
Not applicable By invitation 2026-01 Italy
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA
NCT03829371 · ClinicalTrials.gov ↗ · Multiple Myeloma
Phase 4 Active, closed 2019-01 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University of Turin, Italy trials

8 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University of Turin, Italy trials

36 conditions
Airway Complication of Anesthesia1Critical Illness1Respiratory Failure1Prostate Cancer1Periodontal Diseases1IBD1Dysbiosis1Inflammation1Head and Neck Cancer1Surgery for Head and Neck Cancer Patients1Demolitive Surgical Procedures on the Oral Cavity or Oropharynx, With or Without Simultaneous Reconstruction Using Flaps1Peri-implantitis1GVHD - Graft-Versus-Host Disease1Infections After HSCT1Transplant Associated Microangiopathy TAM1Sinusoidal Obstruction Syndrome (SOS)1Interprofessional Relations1Self Efficacy1Knowledge, Attitudes, Practice1Depression, Anxiety1Post-traumatic Stress Symptoms1Dissociation1Psychotherapy Research and Outcome Measures1SIAD - Syndrome of Inappropriate Antidiuresis1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy1712
Clinical trials in Ireland22
Clinical trials in France22
Clinical trials in India11

A trial with sites in more than one country appears in each of those registers.

05

Questions about University of Turin, Italy trials

How many clinical trials does University of Turin, Italy sponsor?

University of Turin, Italy is the lead sponsor of 17 current trials on ClinicalTrials.gov in our Italy, Ireland, France and India registers, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.

Are University of Turin, Italy trials recruiting?

Yes. 12 of its 17 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of Turin, Italy testing?

Its current trials name 8 drugs and biologicals as interventions. The most frequent are Daratumumab (1), Dexamethasone (1), Lenalidomide (1), Melphalan (1) and Noradrenaline (1). The number in brackets is how many of its trials name each drug.

Does University of Turin, Italy have clinical trials in Ireland?

Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.